Role of Ureteroscopy in Treatment of Upper Tract Urothelial Carcinoma.

ABSTRACT:

Purpose of review

Upper tract urothelial carcinoma (UTUC) is uncommon accounting for less than 10% of all urothelial tumours. Ureteroscopic management (URS) is the first line treatment for low-risk disease and has been increasingly utilised due to technological advances and increasing surgical experience. This review looks at patient outcomes relating to URS, emerging technologies and the role of adjuvant intracavitary therapy in the management of UTUC.

Recent findings

URS has firmly established itself in the management algorithm for UTUC, and a good body of evidence supports its use for low-risk disease, wherein oncological outcomes are comparable to traditional nephroureterectomy (RNU). Larger tumours can now be managed using URS with a lower morbidity than radical surgery

SUBMITTER: Ng Chieng Hin J 

PROVIDER: S-EPMC8497313 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature